Rhumbline Advisers Stryker Corp Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Stryker Corp stock. As of the latest transaction made, Rhumbline Advisers holds 675,960 shares of SYK stock, worth $244 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

675,960

Previous 666,096 1.48%

Holding current value

$244 Million

Previous $238 Million 3.52%

% of portfolio

0.22%

Previous 0.23%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$324.3 - $354.67 $3.2 Million - $3.5 Million	9,864 Added 1.48%	675,960 $230 Million
Q1 2024 May 09, 2024	SELL	$293.94 - $358.71 $567,892 - $693,027	-1,932 Reduced 0.29%	666,096 $238 Million
Q4 2023 Feb 08, 2024	SELL	$253.85 - $299.46 $2.4 Million - $2.83 Million	-9,458 Reduced 1.4%	668,028 $200 Million
Q3 2023 Nov 09, 2023	SELL	$266.54 - $302.43 $1.1 Million - $1.25 Million	-4,145 Reduced 0.61%	677,486 $185 Million
Q2 2023 Aug 08, 2023	BUY	$271.49 - $305.09 $906,776 - $1.02 Million	3,340 Added 0.49%	681,631 $208 Million
Q1 2023 May 11, 2023	BUY	$246.13 - $285.47 $4.94 Million - $5.73 Million	20,069 Added 3.05%	678,291 $194 Million
Q4 2022 Feb 14, 2023	BUY	$205.51 - $253.93 $7.2 Million - $8.89 Million	35,014 Added 5.62%	658,222 $161 Million
Q3 2022 Nov 10, 2022	BUY	$189.27 - $231.83 $1.79 Million - $2.2 Million	9,477 Added 1.54%	623,208 $126 Million
Q2 2022 Aug 11, 2022	BUY	$194.09 - $276.37 $4.59 Million - $6.54 Million	23,669 Added 4.01%	613,731 $122 Million
Q1 2022 May 12, 2022	BUY	$245.33 - $277.77 $5.56 Million - $6.29 Million	22,654 Added 3.99%	590,062 $158 Million
Q4 2021 Feb 10, 2022	BUY	$236.63 - $276.44 $2.72 Million - $3.18 Million	11,497 Added 2.07%	567,408 $152 Million
Q3 2021 Nov 12, 2021	SELL	$248.9 - $280.09 $483,114 - $543,654	-1,941 Reduced 0.35%	555,911 $147 Million
Q2 2021 Aug 05, 2021	SELL	$242.95 - $267.0 $6.1 Million - $6.7 Million	-25,112 Reduced 4.31%	557,852 $145 Million
Q1 2021 May 06, 2021	SELL	$221.01 - $248.82 $15.8 Million - $17.8 Million	-71,526 Reduced 10.93%	582,964 $142 Million
Q4 2020 Feb 10, 2021	SELL	$202.01 - $245.04 $502,398 - $609,414	-2,487 Reduced 0.38%	654,490 $160 Million
Q3 2020 Nov 12, 2020	SELL	$177.77 - $215.81 $1.86 Million - $2.26 Million	-10,488 Reduced 1.57%	656,977 $137 Million
Q2 2020 Aug 13, 2020	BUY	$144.67 - $207.03 $3.2 Million - $4.58 Million	22,135 Added 3.43%	667,465 $120 Million
Q1 2020 May 06, 2020	BUY	$126.5 - $225.1 $331,303 - $589,536	2,619 Added 0.41%	645,330 $107 Million
Q4 2019 Feb 05, 2020	SELL	$197.98 - $220.53 $389,030 - $433,341	-1,965 Reduced 0.3%	642,711 $135 Million
Q3 2019 Oct 23, 2019	BUY	$205.4 - $221.82 $4.62 Million - $4.99 Million	22,515 Added 3.62%	644,676 $139 Million
Q2 2019 Aug 14, 2019	SELL	$180.24 - $205.58 $2.21 Million - $2.52 Million	-12,235 Reduced 1.93%	622,161 $128 Million
Q1 2019 May 01, 2019	BUY	$152.46 - $198.0 $2.46 Million - $3.2 Million	16,158 Added 2.61%	634,396 $125 Million
Q4 2018 Jan 31, 2019	SELL	$145.0 - $178.65 $412,380 - $508,080	-2,844 Reduced 0.46%	618,238 $96.9 Million
Q3 2018 Nov 07, 2018	SELL	$163.25 - $177.68 $3.78 Million - $4.11 Million	-23,151 Reduced 3.59%	621,082 $110 Million
Q2 2018 Aug 06, 2018	BUY	$155.17 - $179.78 $656,524 - $760,649	4,231 Added 0.66%	644,233 $109 Million
Q1 2018 May 02, 2018	SELL	$148.01 - $168.91 $1.58 Million - $1.8 Million	-10,673 Reduced 1.64%	640,002 $103 Million
Q4 2017 Feb 09, 2018	BUY	$143.51 - $159.74 $140,496 - $156,385	979 Added 0.15%	650,675 $101 Million
Q3 2017 Nov 06, 2017	BUY	$138.36 - $147.87 $89.9 Million - $96.1 Million	649,696	649,696 $92.3 Million

Others Institutions Holding SYK

# of Institutions

2,159

Shares Held

285M

Call Options Held

1.13M

Put Options Held

1.1M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Stryker Corp Transaction History